Newstral
Article
San Jose Mercury News on 2022-02-12 15:16
FDA authorizes new monoclonal antibody drug said to work against omicron
Related news
- FDA Authorizes Eli Lilly Antibody Treatment That Fights OmicronForbes
- MNew monoclonal antibody drug for COVID authorized, FDA says. It works against omicronmiamiherald.com
- FDA authorizes new Covid-19 monoclonal antibody that works against Omicron variantCNN
- FDA authorizes new antibody drug to fight omicronpressherald.com
- FDA Authorizes Eli Lilly’s Covid Antibody Therapy For Emergency Use In Young ChildrenForbes
- FDA authorizes antibody treatment given to Trumpisraelnationalnews.com
- FDA authorizes first coronavirus antibody testCNN
- FDA authorizes antibody treatment for COVID-19israelnationalnews.com
- FDA authorizes AstraZeneca's COVID-19 antibody cocktailisraelnationalnews.com
- Texas Exhausts Supply of Monoclonal Antibody Treatment Effective Against Omicronbreitbart.com
- FDA Approves Second Biosimilar – Inflectra™ – The First Monoclonal Antibody Biosimilarjdsupra.com
- Florida shuts down all monoclonal antibody treatment sites after FDA decision to limit use of certain treatments not proven effective against OmicronCNN
- US authorizes new antibody drug to fight omicronSeattle Times
- F.D.A. Authorizes Monoclonal Antibody Drug With Promise Against OmicronThe New York Times
- FDA authorizes first antibody-based test for COVID-19The Verge
- FDA authorizes AstraZeneca COVID antibody treatment for emergency useFox News
- FDA authorizes emergency use of Eli Lilly coronavirus antibody treatmentThe Jerusalem Post (JPost.com)
- FDA Authorizes New Antibody Treatment For Severe Covid-19Forbes
- The FDA authorizes 2 more coronavirus antibody testsCNN